NDC 0310-3080 – Saphnelo
Anifrolumab 120 mg/.8mL · Injection, Solution · Subcutaneous
Product NDC0310-3080
Product details
- Brand name
- Saphnelo
- Generic name
- Anifrolumab-fnia
- Labeler
- AstraZeneca Pharmaceuticals LP
- Dosage form
- Injection, Solution
- Route
- Subcutaneous
- Marketing category
- BLA · BLA761451
- Marketed since
- April 24, 2026
- Listing expires
- December 31, 2027
- Pharmacologic class
- Type I Interferon Receptor Antagonist
Active ingredients
- Anifrolumab 120 mg/.8mL
Package NDC codes (3)
| Package NDC | Description | Since |
|---|---|---|
| 0310-3080-01 | 1 SYRINGE, GLASS in 1 CARTON (0310-3080-01) / .8 mL in 1 SYRINGE, GLASS (0310-3080-25) | Apr 24, 2026 |
| 0310-3080-02 | 1 SYRINGE, GLASS in 1 CARTON (0310-3080-02) / .8 mL in 1 SYRINGE, GLASS (0310-3080-75) | Apr 24, 2026 |
| 0310-3080-95 sample | 1 SYRINGE, GLASS in 1 CARTON (0310-3080-95) / .8 mL in 1 SYRINGE, GLASS (0310-3080-25) | Apr 24, 2026 |
Other Saphnelo products
- 0310-3040 Anifrolumab 300 mg/2mL · Injection, Solution · AstraZeneca Pharmaceuticals LP